Masanori Matsumoto Selected Research

Hemorrhage

2/2022	Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial.
11/2021	Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device support.
4/2021	Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.
12/2020	A rare case of pyogenic granuloma of the jejunum causing gastrointestinal bleeding.
4/2020	Barrett's adenocarcinoma with esophageal varices successfully treated by endoscopic submucosal dissection with direct varices coagulation.
1/2020	[Acquired von Willebrand syndrome].
1/2018	Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.
1/2017	Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions.
10/2016	Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement.
2/2003	Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Matsumoto Research Topics

Disease

72	Thrombotic Thrombocytopenic Purpura 08/2022 - 01/2002
21	Thrombocytopenia (Thrombopenia) 04/2021 - 05/2006
20	Thrombotic Microangiopathies 01/2021 - 12/2003
19	Thrombosis (Thrombus) 01/2022 - 02/2003
16	acquired Thrombotic thrombocytopenic purpura 06/2022 - 09/2002
13	Hemolytic-Uremic Syndrome 01/2022 - 01/2002
12	Hemolytic Anemia 02/2022 - 12/2006
11	Hemorrhage 02/2022 - 01/2002
10	Inflammation (Inflammations) 01/2022 - 09/2008
10	Neoplasms (Cancer) 12/2020 - 01/2004
7	Atypical Hemolytic Uremic Syndrome 01/2019 - 11/2014
6	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022 - 08/2009
5	Hemolysis 06/2021 - 02/2007
5	Liver Diseases (Liver Disease) 01/2017 - 08/2005
5	Renal Insufficiency (Renal Failure) 08/2016 - 01/2005
4	Disseminated Intravascular Coagulation 04/2021 - 01/2018
4	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 11/2018
4	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 01/2004
4	Disease Progression 10/2018 - 01/2005
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2013 - 08/2009
3	Thrombophilia 03/2022 - 05/2019
3	COVID-19 02/2022 - 04/2021
3	Infections 01/2022 - 01/2010
3	Reperfusion Injury 11/2019 - 12/2005
3	Fibrosis (Cirrhosis) 10/2019 - 06/2008
3	Fever (Fevers) 01/2013 - 12/2006
2	Evans Syndrome 01/2022 - 10/2005
2	Macular Degeneration (Age-Related Maculopathy) 10/2021 - 01/2018
2	Wounds and Injuries (Trauma) 06/2021 - 09/2008
2	Constipation 01/2021 - 01/2021
2	Ischemia 01/2021 - 12/2005
2	Esophageal and Gastric Varices (Esophageal Varices) 12/2020 - 04/2020
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 10/2016
2	von Willebrand Diseases (von Willebrand's Disease) 11/2018 - 02/2003
2	Brain Diseases (Brain Disorder) 02/2018 - 04/2015
2	Multiple Organ Failure (MODS) 02/2018 - 09/2017
2	Hepatitis 09/2017 - 01/2010
2	Human Influenza (Influenza) 09/2016 - 01/2010
2	Pancreatitis 04/2016 - 01/2008
2	Acute Kidney Injury (Acute Renal Failure) 04/2015 - 05/2013

Drug/Important Bio-Agent (IBA)

63	thiamine triphosphorate (TTP)IBA 06/2022 - 05/2002
35	von Willebrand FactorIBA 04/2022 - 02/2003
13	Metalloproteases (Metalloproteinases)IBA 06/2022 - 10/2004
13	AutoantibodiesIBA 01/2021 - 01/2002
11	Rituximab (Mabthera)FDA Link 08/2022 - 06/2005
11	ThrombospondinsIBA 06/2022 - 10/2004
11	AntigensIBA 04/2022 - 01/2007
10	DisintegrinsIBA 06/2022 - 10/2004
10	ADAMTS13 ProteinIBA 01/2017 - 01/2002
6	SteroidsIBA 01/2022 - 01/2005
6	Immunoglobulin G (IgG)IBA 11/2019 - 12/2002
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2005
4	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2018
4	Messenger RNA (mRNA)IBA 02/2022 - 08/2005
4	AntibodiesIBA 11/2021 - 10/2005
4	Dacarbazine (DIC)FDA LinkGeneric 04/2021 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
4	eculizumab FDA Link 01/2019 - 04/2015
4	Complement System Proteins (Complement)IBA 10/2018 - 11/2014
4	CytokinesIBA 02/2018 - 02/2010
3	EnzymesIBA 04/2022 - 01/2002
3	EndotoxinsIBA 03/2022 - 02/2010
3	caplacizumabIBA 01/2022 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 01/2018
3	Intravenous Immunoglobulins (IVIG)FDA Link 07/2019 - 02/2007
3	Ticlopidine (Ticlid)FDA LinkGeneric 06/2013 - 02/2009
3	CollagenIBA 09/2012 - 02/2003
2	GlucocorticoidsIBA 08/2022 - 04/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 10/2005
2	Factor VIII (Coagulation Factor VIII)IBA 02/2022 - 01/2008
2	VaccinesIBA 02/2022 - 01/2022
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 11/2017
2	ARC 1779IBA 01/2022 - 11/2020
2	antineoplaston A10 (A 10)IBA 11/2021 - 11/2017
2	AnticoagulantsIBA 04/2021 - 02/2007
2	Lubiprostone FDA Link 01/2021 - 01/2021
2	Capsules (Microcapsules)IBA 12/2020 - 09/2017
2	botrocetinIBA 11/2020 - 07/2012
2	Glycoproteins (Glycoprotein)IBA 11/2020 - 04/2019
2	Hyaluronic Acid (Hyaluronan)IBA 04/2020 - 05/2010
2	Hemostatics (Antihemorrhagics)IBA 04/2020 - 01/2011
2	BilirubinIBA 11/2018 - 12/2016
2	Monoclonal AntibodiesIBA 11/2017 - 02/2008
2	Interleukin-8 (Interleukin 8)IBA 09/2017 - 02/2010
2	InterleukinsIBA 09/2017 - 02/2010
2	ThrombomodulinIBA 04/2015 - 01/2013
2	Bevacizumab (Avastin)FDA Link 01/2015 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 12/2014 - 01/2013
2	CreatinineIBA 05/2013 - 12/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 02/2010
2	Clopidogrel (Plavix)FDA Link 11/2012 - 02/2009

Therapy/Procedure

18	Plasma Exchange 08/2022 - 05/2002
13	Therapeutics 06/2022 - 12/2002
5	Drug Therapy (Chemotherapy) 12/2020 - 10/2008
4	Liver Transplantation 07/2015 - 12/2003
3	Plasmapheresis 01/2022 - 12/2006
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 03/2016
3	Ligation 12/2020 - 08/2009
3	Hepatectomy 11/2019 - 03/2010
2	Heart-Assist Devices 06/2021 - 01/2020